La terapia medica dell'ulcera peptica: problemi e prospettive.

Translated title of the contribution: Medical therapy of peptic ulcer: problems and prospects

E. Trabucchi, D. Foschi, P. Belloli, F. Montorsi, V. Marchetti, C. Mariscotti, S. Diamantini

Research output: Contribution to journalArticle

Abstract

In the last few years, several drugs have been proposed for the healing of peptic ulcers H2 receptor antagonists are probably the reference-drugs for their efficacy and safety. Acute treatment of peptic ulcer with cimetidine, ranitidine or famotidine gives a high healing rate: from 60% to 90%, depending on the location of the ulcer and the drug used. However, relapse after short-term treatment still remains frequent, and prophylaxis of recurrence must be decided. Long-term treatment with antisecretory drugs could be dangerous for changes of the gastric system, with nitrites and nitro-compounds occurrence, and for the risk of frequent relapses. Therefore, the role of mucus-barrier drugs and surgery must be reconsidered.

Original languageItalian
Pages (from-to)1-6
Number of pages6
JournalMinerva Dietologica e Gastroenterologica
Volume35
Issue number1
Publication statusPublished - Jan 1989

Fingerprint

Peptic Ulcer
Pharmaceutical Preparations
Recurrence
Nitro Compounds
Famotidine
Therapeutics
Histamine H2 Receptors
Ranitidine
Cimetidine
Mucus
Nitrites
Ulcer
Stomach
Safety

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Trabucchi, E., Foschi, D., Belloli, P., Montorsi, F., Marchetti, V., Mariscotti, C., & Diamantini, S. (1989). La terapia medica dell'ulcera peptica: problemi e prospettive. Minerva Dietologica e Gastroenterologica, 35(1), 1-6.

La terapia medica dell'ulcera peptica : problemi e prospettive. / Trabucchi, E.; Foschi, D.; Belloli, P.; Montorsi, F.; Marchetti, V.; Mariscotti, C.; Diamantini, S.

In: Minerva Dietologica e Gastroenterologica, Vol. 35, No. 1, 01.1989, p. 1-6.

Research output: Contribution to journalArticle

Trabucchi, E, Foschi, D, Belloli, P, Montorsi, F, Marchetti, V, Mariscotti, C & Diamantini, S 1989, 'La terapia medica dell'ulcera peptica: problemi e prospettive.', Minerva Dietologica e Gastroenterologica, vol. 35, no. 1, pp. 1-6.
Trabucchi E, Foschi D, Belloli P, Montorsi F, Marchetti V, Mariscotti C et al. La terapia medica dell'ulcera peptica: problemi e prospettive. Minerva Dietologica e Gastroenterologica. 1989 Jan;35(1):1-6.
Trabucchi, E. ; Foschi, D. ; Belloli, P. ; Montorsi, F. ; Marchetti, V. ; Mariscotti, C. ; Diamantini, S. / La terapia medica dell'ulcera peptica : problemi e prospettive. In: Minerva Dietologica e Gastroenterologica. 1989 ; Vol. 35, No. 1. pp. 1-6.
@article{20f3a5340a9f4fc4afc8dacc9b62f4ae,
title = "La terapia medica dell'ulcera peptica: problemi e prospettive.",
abstract = "In the last few years, several drugs have been proposed for the healing of peptic ulcers H2 receptor antagonists are probably the reference-drugs for their efficacy and safety. Acute treatment of peptic ulcer with cimetidine, ranitidine or famotidine gives a high healing rate: from 60{\%} to 90{\%}, depending on the location of the ulcer and the drug used. However, relapse after short-term treatment still remains frequent, and prophylaxis of recurrence must be decided. Long-term treatment with antisecretory drugs could be dangerous for changes of the gastric system, with nitrites and nitro-compounds occurrence, and for the risk of frequent relapses. Therefore, the role of mucus-barrier drugs and surgery must be reconsidered.",
author = "E. Trabucchi and D. Foschi and P. Belloli and F. Montorsi and V. Marchetti and C. Mariscotti and S. Diamantini",
year = "1989",
month = "1",
language = "Italian",
volume = "35",
pages = "1--6",
journal = "Minerva Gastroenterologica",
issn = "0026-4776",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - La terapia medica dell'ulcera peptica

T2 - problemi e prospettive.

AU - Trabucchi, E.

AU - Foschi, D.

AU - Belloli, P.

AU - Montorsi, F.

AU - Marchetti, V.

AU - Mariscotti, C.

AU - Diamantini, S.

PY - 1989/1

Y1 - 1989/1

N2 - In the last few years, several drugs have been proposed for the healing of peptic ulcers H2 receptor antagonists are probably the reference-drugs for their efficacy and safety. Acute treatment of peptic ulcer with cimetidine, ranitidine or famotidine gives a high healing rate: from 60% to 90%, depending on the location of the ulcer and the drug used. However, relapse after short-term treatment still remains frequent, and prophylaxis of recurrence must be decided. Long-term treatment with antisecretory drugs could be dangerous for changes of the gastric system, with nitrites and nitro-compounds occurrence, and for the risk of frequent relapses. Therefore, the role of mucus-barrier drugs and surgery must be reconsidered.

AB - In the last few years, several drugs have been proposed for the healing of peptic ulcers H2 receptor antagonists are probably the reference-drugs for their efficacy and safety. Acute treatment of peptic ulcer with cimetidine, ranitidine or famotidine gives a high healing rate: from 60% to 90%, depending on the location of the ulcer and the drug used. However, relapse after short-term treatment still remains frequent, and prophylaxis of recurrence must be decided. Long-term treatment with antisecretory drugs could be dangerous for changes of the gastric system, with nitrites and nitro-compounds occurrence, and for the risk of frequent relapses. Therefore, the role of mucus-barrier drugs and surgery must be reconsidered.

UR - http://www.scopus.com/inward/record.url?scp=0024499559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024499559&partnerID=8YFLogxK

M3 - Articolo

C2 - 2566959

AN - SCOPUS:0024499559

VL - 35

SP - 1

EP - 6

JO - Minerva Gastroenterologica

JF - Minerva Gastroenterologica

SN - 0026-4776

IS - 1

ER -